Tarja Ojanen

431 total citations
18 papers, 347 citations indexed

About

Tarja Ojanen is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Tarja Ojanen has authored 18 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Pharmacology. Recurrent topics in Tarja Ojanen's work include Antifungal resistance and susceptibility (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Fungal Infections and Studies (3 papers). Tarja Ojanen is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Fungal Infections and Studies (3 papers). Tarja Ojanen collaborates with scholars based in Finland, Türkiye and Kazakhstan. Tarja Ojanen's co-authors include R. Mäntyjärvi, Halise İnci Gül, E. O. Terho, T. Nousiainen, Sini Suomalainen, Juha Kauppinen, S. Aukee, M Katila, Toivo Naaranlahti and Viswanath P. Kurup and has published in prestigious journals such as European Respiratory Journal, International Journal of Epidemiology and Allergy.

In The Last Decade

Tarja Ojanen

18 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarja Ojanen Finland 11 78 76 69 63 58 18 347
Monica Lundholm Sweden 16 161 2.1× 205 2.7× 39 0.6× 404 6.4× 47 0.8× 28 792
Donald C. Mackel United States 6 32 0.4× 20 0.3× 34 0.5× 6 0.1× 65 1.1× 9 299
D. Marmet France 9 16 0.2× 27 0.4× 15 0.2× 40 0.6× 40 0.7× 17 320
Shashi Bhushan Kumar United States 7 43 0.6× 17 0.2× 51 0.7× 13 0.2× 29 0.5× 17 402
Eun‐Ik Koh United States 6 20 0.3× 13 0.2× 46 0.7× 34 0.5× 32 0.6× 8 278
Eleonora Cremonini Italy 7 13 0.2× 30 0.4× 61 0.9× 25 0.4× 67 1.2× 10 415
M. H. Robertson United Kingdom 9 25 0.3× 21 0.3× 16 0.2× 14 0.2× 70 1.2× 17 258
Haojiang Zuo China 13 20 0.3× 26 0.3× 49 0.7× 51 0.8× 38 0.7× 39 386
Zhen Lan China 10 26 0.3× 19 0.3× 33 0.5× 79 1.3× 39 0.7× 16 438
Necati Timurkaan Türkiye 8 20 0.3× 16 0.2× 55 0.8× 63 1.0× 39 0.7× 39 333

Countries citing papers authored by Tarja Ojanen

Since Specialization
Citations

This map shows the geographic impact of Tarja Ojanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarja Ojanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarja Ojanen more than expected).

Fields of papers citing papers by Tarja Ojanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarja Ojanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarja Ojanen. The network helps show where Tarja Ojanen may publish in the future.

Co-authorship network of co-authors of Tarja Ojanen

This figure shows the co-authorship network connecting the top 25 collaborators of Tarja Ojanen. A scholar is included among the top collaborators of Tarja Ojanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarja Ojanen. Tarja Ojanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gül, Halise İnci, Tarja Ojanen, Jouko Vepsäläinen, et al.. (2011). Antifungal Activity of Some Mono, Bis and Quaternary Mannich Bases Derived from Acetophenone. Arzneimittelforschung. 51(1). 72–75. 15 indexed citations
2.
Turpeinen, Miia, et al.. (2003). Stability of sufentanil and levobupivacaine solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes. European Journal of Pharmaceutical Sciences. 19(1). 31–36. 21 indexed citations
3.
Nousiainen, T., Sini Suomalainen, S. Aukee, et al.. (2002). Recurrent Sphingomonas paucimobilis -bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients. Journal of Hospital Infection. 50(3). 196–201. 78 indexed citations
4.
Gül, Halise İnci, et al.. (2002). Antifungal Evaluation of Bis Mannich Bases Derived from Acetophenones and Their Corresponding Piperidinols and Stability Studies. Biological and Pharmaceutical Bulletin. 25(10). 1307–1310. 47 indexed citations
5.
Naaranlahti, Toivo, et al.. (2001). Enteral suspension of nifedipine for neonates. Part 2. Stability of an extemporaneously compounded nifedipine suspension. Journal of Clinical Pharmacy and Therapeutics. 26(1). 59–66. 7 indexed citations
6.
Örmälä, Timo, et al.. (1995). Prospective evaluation of Candida antigen and antibody assays for detection of Candida infections in children with malignant disease. Acta Paediatrica. 84(2). 183–187. 5 indexed citations
7.
Örmälä, Timo, Matti Korppi, Marja‐Leena Katila, Tarja Ojanen, & Kirsti Heinonen. (1992). Fungal Gut Colonization with Candida or Pityrosporum sp. and Serum Candida Antigen in Preterm Neonates with Very Low Birth Weights. Scandinavian Journal of Infectious Diseases. 24(6). 781–785. 10 indexed citations
8.
Ojanen, Tarja. (1992). Class specific antibodies in serodiagnosis of farmer's lung.. Occupational and Environmental Medicine. 49(5). 332–336. 15 indexed citations
9.
Ojanen, Tarja, et al.. (1990). Class-specific antibodies during follow up of patients with farmer's lung. European Respiratory Journal. 3(3). 257–260. 20 indexed citations
10.
Rautalahti, Matti, E. O. Terho, & Tarja Ojanen. (1990). Changes in the titers of IgG antibodies against farmer's lung antigens in the sera of healthy dairy farmers.. PubMed. 64(5). 455–8. 6 indexed citations
11.
Kurup, Viswanath P., et al.. (1987). Circulating IgG antibodies against fungal and actinomycete antigens in the sera of farmer's lung patients from different countries. Mycopathologia. 98(2). 91–99. 26 indexed citations
12.
Ojanen, Tarja, et al.. (1986). Significance of IgG antibodies against environmental microbial antigens in a farming population. Clinical & Experimental Allergy. 16(5). 459–467. 7 indexed citations
13.
Katila, Marja‐Leena, Tarja Ojanen, & Rauno Mäntyjärvi. (1986). A six‐year follow‐up of antibody levels against microbes present in the farming environment in a group of dairy farmers in finland. American Journal of Industrial Medicine. 10(3). 307–309. 4 indexed citations
14.
Terho, Erkki O., et al.. (1985). Familial Aggregation of IgG Antibody Response to Antigens Associated with Farmer's Lung. International Journal of Epidemiology. 14(4). 589–593. 14 indexed citations
15.
Ojanen, Tarja, R. Mäntyjärvi, Henri Seppänen, et al.. (1983). Exposure of water consumers to mesophilic actinomycetes. Journal of Hygiene. 91(3). 535–541. 5 indexed citations
16.
Ojanen, Tarja, E. O. Terho, & R. Mäntyjärvi. (1982). Comparison of Aspergillus fumigatus and Aspergillus umbrosus Antigens in Serological Tests of Farmer's Lung. Allergy. 37(5). 297–301. 12 indexed citations
17.
Mäntyjärvi, R., et al.. (1981). Sensitisation against environmental antigens and respiratory symptoms in swine workers.. Occupational and Environmental Medicine. 38(4). 334–338. 26 indexed citations
18.
Ojanen, Tarja, et al.. (1980). The Use of Enzyme‐Linked Immunosorbent Assay (ELISA) in the Diagnosis of Farmer's Lung. Allergy. 35(6). 537–542. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026